[go: up one dir, main page]

ES2192256T3 - Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas. - Google Patents

Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.

Info

Publication number
ES2192256T3
ES2192256T3 ES97600009T ES97600009T ES2192256T3 ES 2192256 T3 ES2192256 T3 ES 2192256T3 ES 97600009 T ES97600009 T ES 97600009T ES 97600009 T ES97600009 T ES 97600009T ES 2192256 T3 ES2192256 T3 ES 2192256T3
Authority
ES
Spain
Prior art keywords
paracetamol
combinations
active substances
solutions containing
injectable pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97600009T
Other languages
English (en)
Inventor
Ioulia K Tseti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uni Pharma Kleon Tsetis A B E
Original Assignee
Uni Pharma Kleon Tsetis A B E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8230107&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2192256(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uni Pharma Kleon Tsetis A B E filed Critical Uni Pharma Kleon Tsetis A B E
Application granted granted Critical
Publication of ES2192256T3 publication Critical patent/ES2192256T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTAS SOLUCIONES COMPRENDEN COMO INGREDIENTE O INGREDIENTES ACTIVOS PARACETAMOL Y COMBINACIONES DE PARACETAMOL CON EL ESPAMOLITICO HYOSCINE-N-BUTIL-BROMURO Y EL ANALGESICO FOSFATO DE CODEINA EN DONDE EL SOLVENTE EN TODOS LOS CASOS CONSTA DE ETANOL, AGUA BIDESTILADA Y ESTERILIZADA Y GLICEROL FORMAL O ALCOHOL BENCILICO, AGUA Y GLICEROL FORMAL EN LA RELACION DE 10, 40 KA AL IO 50% POR VOLUMEN. LA SOLUCION TAMBIEN COMPREN DEN LIDOCAINA COMO ANESTESICO LOCAL Y EDETATO DISODIO, METABISULFITO DE SODIO, FOSFATO DIBASICO DE SODIO, NIPAGIN A Y NIPANSOL M, EXCIPIENTES QUE ASEGURAN LA ESTABILIDAD DE LAS SOLUCIONES Y EL MANTENIMIENTO DEL PH EN LOS LIMITES DESEADOS DE 5,0 - 6,5.
ES97600009T 1997-11-18 1997-11-18 Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas. Expired - Lifetime ES2192256T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97600009A EP0916347B1 (en) 1997-11-18 1997-11-18 Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances

Publications (1)

Publication Number Publication Date
ES2192256T3 true ES2192256T3 (es) 2003-10-01

Family

ID=8230107

Family Applications (2)

Application Number Title Priority Date Filing Date
ES97600009T Expired - Lifetime ES2192256T3 (es) 1997-11-18 1997-11-18 Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
ES02023125T Expired - Lifetime ES2265470T3 (es) 1997-11-18 1997-11-18 Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02023125T Expired - Lifetime ES2265470T3 (es) 1997-11-18 1997-11-18 Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.

Country Status (8)

Country Link
EP (2) EP1285667B1 (es)
AT (2) ATE329621T1 (es)
CY (1) CY2562B1 (es)
DE (2) DE69719189T2 (es)
DK (2) DK0916347T3 (es)
ES (2) ES2192256T3 (es)
PT (2) PT1285667E (es)
SI (2) SI1285667T1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
EP1469885A1 (en) * 2001-12-18 2004-10-27 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteral composition of paracetamol
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
WO2008009756A1 (es) * 2006-07-18 2008-01-24 Genfarma Laboratorio S.L. Formulación líquida inyectable de paracetamol
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
EP2464332B2 (en) 2009-08-13 2025-10-15 Neogen N.V. Method for producing a storage-stable formulation of paracetamol in aqueous solution
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PT2588097T (pt) 2010-06-30 2021-05-25 Troikaa Pharmaceuticals Ltd Composições farmacêuticas que compreendem paracetamol e processo para preparar as mesmas
JO3400B1 (ar) 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
CN103476395A (zh) 2011-02-10 2013-12-25 尼奥根公司 在水溶液中贮存稳定的扑热息痛制剂
JP6063877B2 (ja) 2011-03-10 2017-01-18 ゼリス ファーマシューティカルズ インコーポレイテッド ペプチド薬物の非経口注射用の安定な製剤
DK2773331T3 (en) 2011-10-31 2016-03-14 Xeris Pharmaceuticals Inc Formulations for the treatment of diabetes
US9125805B2 (en) * 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
US11129940B2 (en) 2014-08-06 2021-09-28 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
ES2982668T3 (es) 2017-06-02 2024-10-17 Xeris Pharmaceuticals Inc Formulaciones de fármacos de moléculas pequeñas resistentes a la precipitación
GB201811858D0 (en) * 2018-07-20 2018-09-05 Wockhardt Uk Ltd Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111591A1 (de) * 1981-03-24 1982-10-14 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Blutdrucksenkendes arzneimittel
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GR1001523B (el) * 1991-07-04 1994-01-28 Uni Pharma Tsetis Kleon Farmak Ενέσιμα διαλύματα του συνδυασμού παρακεταμόλης και κωδεϊνης.
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
GR1002731B (el) * 1996-10-21 1997-07-04 Uni-Pharma ����� ������ �.�.�.�. ������������ ���������� Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Also Published As

Publication number Publication date
DK1285667T3 (da) 2006-09-11
EP0916347A1 (en) 1999-05-19
DK0916347T3 (da) 2003-04-22
ES2265470T3 (es) 2007-02-16
HK1020866A1 (en) 2000-05-26
PT1285667E (pt) 2006-11-30
EP1285667A3 (en) 2003-03-26
EP1285667A2 (en) 2003-02-26
DE69736140D1 (de) 2006-07-27
ATE329621T1 (de) 2006-07-15
EP0916347B1 (en) 2003-02-19
CY2562B1 (en) 2008-07-02
ATE232741T1 (de) 2003-03-15
EP1285667B1 (en) 2006-06-14
DE69719189T2 (de) 2003-11-27
DE69719189D1 (de) 2003-03-27
PT916347E (pt) 2003-07-31
SI0916347T1 (en) 2003-06-30
SI1285667T1 (sl) 2006-10-31
DE69736140T2 (de) 2007-04-19

Similar Documents

Publication Publication Date Title
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2082288T3 (es) Composiciones terapeuticas para administracion intranasal de ketorolaco.
FI863664A0 (fi) Emulsionskompositioner foer dosering av i vatten svaorloesliga joniserbara hydrofoba laekemedel.
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
ATE15596T1 (de) Pharmazeutische mittel.
DE60019334D1 (de) Antivirale arznei
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
ES2099649T3 (es) Nueva composicion farmaceutica destinada para la fabricacion de un polvo estable que contiene, a titulo de ingrediente activo, una asociacion de acido acetilsalicilico y de metoclopramida.
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
ES548988A0 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
ES2095531T3 (es) Derivados de 17-beta-aril- y 17-beta-heterociclil-5-beta,14-beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung